DiNardo Andrew R, Guy Elizabeth
a Global and Immigrant Health , Baylor College of Medicine , Houston , TX , USA.
b Pulmonology, Department of Internal Medicine , Baylor College of Medicine , Houston , TX , USA.
Expert Rev Anti Infect Ther. 2016;14(5):501-9. doi: 10.1586/14787210.2016.1173541.
The incidence and death rates from tuberculosis (TB) have declined through concerted efforts in the diagnosis and treatment of active disease. Despite this, 9.6 million new cases and 1.1 million deaths in 2014 are unacceptably high. To decrease the rates of TB further, the huge number of persons with latent TB infection (LTBI) from whom new cases will arise has to be addressed with a sense of priority. Identifying the highest risk groups and providing effective treatment has been shown to decrease active TB. Further research to refine the predictors of reactivation and shorter effective treatments are urgently needed. Implementing intensified case finding, testing and treatment for LTBI will require continued investment in health care capacity at multiple levels.
通过在活动性疾病的诊断和治疗方面的共同努力,结核病(TB)的发病率和死亡率有所下降。尽管如此,2014年960万新发病例和110万死亡人数仍高得令人无法接受。为了进一步降低结核病发病率,必须优先解决大量潜伏性结核感染(LTBI)人群的问题,因为新发病例将由此产生。已证明识别最高风险群体并提供有效治疗可减少活动性结核病。迫切需要进一步研究以完善再激活的预测指标并缩短有效治疗时间。对LTBI实施强化病例发现、检测和治疗将需要在多个层面持续投资于卫生保健能力。